The AHA yesterday announced support for the Opioid Workforce Act of 2019, bipartisan legislation to reduce the nation’s shortage of opioid treatment providers by increasing the number of resident physician slots in hospitals with programs focused on substance use disorder treatment. “Your legislation would address existing shortages by adding 1,000 Medicare-funded training positions in approved residency programs in addiction medicine, addiction psychiatry or pain management,” AHA said in a letter to Rep. Brad Schneider, D-Ill., the bill’s author. “These new slots would constitute a major step toward increasing access to SUD treatment for communities in need.” Schneider is joined in introducing the legislation by Reps. Susan Brooks, R-Ind., Ann Kuster, D-N.H., and Elise Stefanik, R-N.Y.

Headline
The Senate April 23 adopted a budget resolution by a 50-48 vote, paving the way for a narrow reconciliation bill focused on immigration enforcement funding.…
Headline
America’s hospitals and health systems are deeply committed to providing high-quality, accessible and affordable care, AHA President and CEO Rick Pollack March…
Headline
The Food and Drug Administration March 5 issued a request for information seeking public comments on potential new standards for in-home opioid disposal…
Headline
The AHA provided a statement Feb. 24 for a House Ways and Means Health Subcommittee hearing titled “Advancing the Next Generation of America’s Health Care…
Perspective
Public
Abraham Lincoln, among those whose legacy we honor with Presidents Day next week, might have put it this way: Thirteen score and three days from now… …
Headline
The Senate Special Committee on Aging held a hearing Feb. 11 on issues impacting physician burnout. The AHA provided a statement for the hearing and urged…